Combating Rituximab-Induced Side Effects

12:15 EST 1 Dec 2016 | OncoTherapy Network

I currently have a 77-year-old non-Hodgkin lymphoma patient that recently started bendamustine (Treanda)/rituximab combination therapy. After increasing the intravenous (IV) rituximab rate per protocol, she developed chills.

Original Article: Combating Rituximab-Induced Side Effects


More From BioPortfolio on "Combating Rituximab-Induced Side Effects"

Quick Search

Relevant Topics

Hodgkin lymphoma
Hodgkin Lymphoma is a  disorder caused by malignant proliferation of lymphocytes, which contain characteristic mirror-image nuclei (Reed-Sternburg cells). The resulting lymphadenopathy can be limited to a single lymph node region (Stage 1) or spread...

Monoclonal antibodies MAbs
Monoclonal antibodies recognise and attach to specific proteins produced by cells.  Types of monoclonal antibodies used to treat cancer cells: Block cell dividing dividing signals Transport cancer drugs or radiation to cancer cells Tr...